Johnson & Johnson tops quarterly profit estimates as medical device sales jump
Summary by CNBC
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
0 Articles
0 Articles
All
Left
Center
Right
CNBC
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
Johnson & Johnson’s profit beats as sales fall slightly short of estimates
Johnson & Johnson’s stock fell 0.4% early Tuesday, after the healthcare company posted better-than-expected profit for the first quarter but sales that fell slightly short of expectations.
Johnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectations
Johnson & Johnson’s recent investments in medical devices helped boost sales, but the company’s total revenue in the first quarter of the year failed to beat Wall Street expectations.Read more...
